SCD1 Inhibitor

Galmed Reports Aramchol Data in Prostate Cancer Models

Ramat Gan, Israel, August 17, 2026 Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and oncology...

By cGxPwire Editor
August 18, 2026

Bio-Pharma

Galmed Advances Brain-Targeted Aramchol for Parkinson’s

Ramat-Gan, Israel, July 28, 2026 Galmed Pharmaceuticals Ltd. has announced a significant advancement in the development of Aramchol orally...

By cGxPwire Editor
July 29, 2026

Bio-Pharma

Galmed Accelerates Heart Failure Innovation with Aramchol

RAMAT-GAN, Israel, July 16, 2026 Galmed Pharmaceuticals Ltd. has announced the breakthrough development of a novel lipid nanoparticle (LNP)...

By cGxPwire Editor
July 18, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Galmed Reports Aramchol Data in Prostate Cancer Models

Galmed Advances Brain-Targeted Aramchol for Parkinson’s

Galmed Accelerates Heart Failure Innovation with Aramchol